Swiss stocks - Factors to watch on Oct. 5

1 分钟阅读

ZURICH/BERLIN, Oct 5 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday:

ROCHE

Roche on Thursday said U.S. regulators approved expanded use of its drug Hemlibra to include almost all patients with hemophilia A, as the Swiss drugmaker increases its focus on diseases beyond cancer to help replace revenue from older products that have lost patent protection.

COMPANY STATEMENTS

EMS-Chemie Holding affirmed its full-year guidance as it reported an 11 percent gain in nine-month sales.